Navigation Links
NIH and non-profits sign research and development agreement
Date:5/25/2011

The National Institutes of Health today announced an agreement with two non-profit organizations to accelerate the development of potential clinical therapies for rare blood cancers.

The cooperative research and development agreement has been established as a shared commitment to move therapies for rare blood cancers into clinical proof-of-concept studies so that promising treatments can eventually be commercialized. The agreement is among the University of Kansas Medical Center, Kansas City, The Leukemia & Lymphoma Society (LLS), the NIH Therapeutics for Rare and Neglected Diseases (TRND) program and the Hematology Branch within the National Heart, Lung and Blood Institute.

"The goal of this collaboration, called The Learning Collaborative (TLC) is to bridge the gap in time and resources that often exists between basic research and human testing of potential new treatments and accelerate and make more efficient the delivery of improved therapies to patients with rare blood cancers," said Christopher P. Austin, M.D., director of the TRND program, currently administered by the National Human Genome Research Institute, a part of NIH. "As a result of our work, as the TLC name implies, we plan to learn more about and improve the drug development process for all diseases."

"This agreement recognizes that academic, philanthropic and patient organizations have a role and a responsibility to be active leaders in the drug discovery process," added Roy A. Jensen, M.D., director, The University of Kansas Cancer Center, Kansas City. "I hope this agreement can serve as a model to other academic and patient communities."

The collaboration's first project is a pilot effort under the TRND program that focuses on further development of an existing small molecule drug used to treat arthritis called auranofin. Auranofin will be evaluated as a treatment for relapsed chronic lymphocytic leukemia (CLL) one of the four major types of leukemia
'/>"/>

Contact: Geoff Spencer
spencerg@mail.nih.gov
301-451-8325
NIH/National Human Genome Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Hope Shoppe Inc. Accepts Submissions for Seasons of Hope and Donates Proceeds to Non-Profits
2. VoiceNation Helps Non-Profits Gather Funding for Those in Need
3. Research study reveals profile for female drunk-drivers
4. Research suggests that lipofilling may be safe during conservation treatment for breast cancer
5. 24th ECNP Congress: The most promising data from research across brain disorders
6. MIT research: What makes an image memorable?
7. UTMB researcher receives $3 million NIH grant to study aging in Mexico
8. Researchers Find Cousin of Hepatitis C Virus in Dogs
9. Researchers discover link between obesity gene and breast cancer
10. Mount Sinai researchers discover possible new target for sarcoma treatment and prevention
11. Research provides insight into quality of stored blood used for transfusions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Power Systems is proud to announce the sponsorship of ... is in his second year of racing in the professional ... Fire Department in Missoula, MT. He entered the triathlon scene ... career, he has had 15 1st Place finishes. In his ... in all seven of his 2014 races, including two 2nd ...
(Date:5/22/2015)... ZH Healthcare (ZH), ... today that Bill Lane, joins ZH’s Advisory Board. ... BlueEHS,a first of its kind, Freemium SaaS, Electronic ... Health Records (EHR) with an integrated practice management ... patient portal, and more. Combined with its Revenue ...
(Date:5/22/2015)... Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they are ... cosmetic, restorative and other dental treatments. At consultations, ... interest them. Questions regarding what certain treatments can ... also be covered during this initial appointment. If ...
(Date:5/22/2015)... NY (PRWEB) May 22, 2015 Medivo, Inc., ... “Positivity Rates and Genotype Results in ‘Baby Boomers’ Screened ... from a Nationwide Lab Test Database” at Digestive Disease Week, ... Medivo’s Clinical Affairs and Analytics team members Carol Smyth, MB; ... and Andrea Parker, MSI, along with Nancy Reau, MD from ...
(Date:5/22/2015)... 22, 2015 A Phase 3 ... American Society of Clinical Oncology (ASCO)’s annual meeting ... rates for those patients who received bevacizumab in ... pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, Inc.) is an antibody ... is already routinely used to treat many other ...
Breaking Medicine News(10 mins):Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2
... more harm than good according to a new Canadian ... researchers revealed that babies born to mothers who take ... of a likelihood of having a lower birth weight ... to the belief that treating depressed mothers-to-be lessens the ...
... households has revealed that nearly 40 per cent of ... and facilities,// especially during the bygone three months. ... Canadians has shown that 81 per cent of households ... felt the waiting times were unwarranted. Many felt that ...
... The World Health Organisation (WHO) has introduced a coordinated ... severe shortage of health workers to handle// HIV/AIDS-related cases. ... Asia (mainly Bangladesh, India and Indonesia) are facing acute ... countries. ,The WHO’s plan ‘Treat, Train, Retain’ ...
... Indian American physician who was four times named as one ... Washingtonian magazine polls, is dead.// ,The physician who specialised ... at Southern Maryland Hospital Center, died of complications from diabetes ... ,Born in Tamil Nadu, Dr. Mani graduated from Madras ...
... Examination Board (MPPEB) will hold afresh next month the Dental ... and dental colleges. // ,The test conducted Aug ... that probed the complaints cancelled the examination Aug 19. ... entrance examinations in a way so that the results can ...
... an answer to preventing many forms of cancer relapse is ... company from Oxford University will be conducting the trials for ... for Cancer Research in Manchester were the ones who initially ... to why the immune system does not see cancer cells ...
Cached Medicine News:
(Date:5/22/2015)... 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... executive officer Howie Rosen will be presenting ... Tim Morris will be presenting at JMP ... are as follows: Jefferies 2015 Healthcare Conference ...
(Date:5/21/2015)... May 21, 2015 Research ... addition of the "North American Active Wound ... Application (Surgical Wound, & Ulcer), by End-User (In-Patient, ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... is estimated to grow at a CAGR of ...
(Date:5/21/2015)...  Cardica, Inc. (Nasdaq: CRDC ) today announced that ... the company,s vice president of operations, was granted an option ... a per share exercise price of $0.43, the closing trading ... pursuant to Cardica, Inc.,s Inducement Plan, which was approved by ... 5653(c)(4) of the Nasdaq Global Market for equity grants to ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2Cardica Announces New Employment Inducement Grant 2
... Dr. Yahia Gawad, CEO of CardioGenics Inc. (OTC Bulletin Board: ... this month,s Medical Device & Diagnostic Industry Magazine ... point-of-care technology. In the article, titled "Improving Diagnosis Times ... diagnostics market and the growth of point-of-care testing. ...
... recent KLAS survey of 137 healthcare providers show high ... (OIS), MOSAIQ ® Radiation Oncology / MOSAIQ ® ... open-system, vendor-independent OIS—earned the top ranking. In addition, 88 ... In the KLAS 2010 report , ...
Cached Medicine Technology:CardioGenics Featured on Cover of Medical Device & Diagnostic Industry Magazine 2Healthcare Providers Rate Elekta's MOSAIQ Oncology Information System as No. 1 in 2010 KLAS Report 2Healthcare Providers Rate Elekta's MOSAIQ Oncology Information System as No. 1 in 2010 KLAS Report 3
... gloves were designed with the surgeon in ... protection, and value. It offers comfort and ... dry hands. The broader, anatomical design allows ... surface offers sensitivity and an effective grip, ...
The Next Generation in Operating Room Equipment and Management Solutions is here Today. NuBoom is a self-contained, pedestal-mounted boom that houses medical, audio and visual equipment....
... versatility and positioning, look to BERCHTOLD's OPERON ... design and 770 lb. weight capacity ensures ... specialties and patient sizes. The radiolucent phenolic ... with a C-arm. An intuitive remote control ...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z37,158-0) ... assistance. Color: colour-coded ...
Medicine Products: